Recherche
Biomarqueurs pour une Médecine de Précision : A. Thierry

Liste des Publications

de Pellegars-Malhortie A, Picque Lasorsa L, Mazard T, Granier F, Prévostel C Why Is Wnt/?-Catenin Not Yet Targeted in Routine Cancer Care?. Pharmaceuticals (Basel). 2024;17(7):949. doi:10.3390/ph17070949

Linares Díaz J, Edwards J, Deleu A-L, Giaj-Levra N, Prisciandaro E, Paesmans M, Berghmans T, Brandão M What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?-A Review of Implications for Diagnosis and Treatment. Cancers (Basel). 2024;16(15):2673. doi:10.3390/cancers16152673

El Osmani N, Prévostel C, Picque Lasorsa L, El Harakeh M, Radwan Z, Mawlawi H, El Sabban M, Shirinian M, Dassouki Z Vitamin C enhances co-localization of novel TET1 nuclear bodies with both Cajal and PML bodies in colorectal cancer cells. Epigenetics. 2024;19(1):2337142. doi:10.1080/15592294.2024.2337142

Adenis A, Ghiringhelli F, Gauthier L, Mazard T, Evesque L, Evrard A, Chalbos P, Moussion A, Gourgou S, Ychou M Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study. Cancer Chemother Pharmacol. 2024;94(3):443-452. doi:10.1007/s00280-024-04682-4

Mazard T, Mollevi C, Loyer E, Léger J, Chautard R, Bouché O, Borg C, Armand-Dujardin P, Bleuzen A, Assenat E, Lecomte T Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial. Cancer Imaging. 2024;24(1):77. doi:10.1186/s40644-024-00722-7

Sauvageot S, Mollevi C, Thomas Q, Charissoux M, Darlix A, Rigau V, Bauchet L, Quantin X, Pujol J, Boetto J Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers. J Neurosurg. 2024;141(1):89-99. doi:10.3171/2023.11.JNS231923

Flecchia C, Auclin E, Alouani E, Mercier M, Hollebecque A, Turpin A, Mazard T, Pernot S, Dutherage M, Cohen R, Borg C, Hautefeuille V, Sclafani F, Ben-Abdelghani M, Aparicio T, Herve C, Perkins G, Heinrich K, Kunzmann V, Gallois C, Guimbaud R, Tougeron D, Taieb J Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study. Br J Cancer. 2024;130(3):442-449. doi:10.1038/s41416-023-02524-3

Mirandola A, Kudriavtsev A, Cofre Muñoz C, Navarro R, Macagno M, Daoud S, Sanchez C, Pastor B, Pisareva E, Marin M, Ruiz J, Piris A, Rodriguez A, Gonzalez N, Vivancos A, Quarà V, Mellano A, Borghi F, Corti G, Marchiò C, Sapino A, Bartolini A, Crisafulli G, Bardelli A, Di Maio M, Lossaint G, Frayssinoux F, Crapez E, Ychou M, Soler R, Fenocchio E, Fernandez Calotti P, Mazard T, Vivas C, Elez E, Di Nicolantonio F, Thierry A Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer. EBioMedicine. 2024;108. doi:10.1016/j.ebiom.2024.105352

Thierry A, Salmon D Inflammation-, immunothrombosis,- and autoimmune-feedback loops may lead to persistent neutrophil self-stimulation in long COVID. J Med Virol. 2024;96(8):e29887. doi:10.1002/jmv.29887

Pisareva E, Mirandola A, Sanchez C, Pastor B, Tanos R, Frayssinoux F, Diab-Assaf M, Anker P, Al Amir Dache Z, Thierry A Impact of platelet activation on the release of cell-free mitochondria and circulating mitochondrial DNA. Clin Chim Acta. 2024;553. doi:10.1016/j.cca.2023.117711

Cristol J-P, Thierry A, Bargnoux A-S, Morena-Carrere M, Canaud B Corrigendum: What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?. Front Med (Lausanne). 2024;11. doi:10.3389/fmed.2024.1393023

Kapoor S, Mihalovi?ová L, Pisareva E, Pastor B, Mirandola A, Bryant J, Princy A, Chouaib S, Thierry A Association of vascular netosis with COVID-19 severity in asymptomatic and symptomatic patients. iScience. 2024;27(5):109573. doi:10.1016/j.isci.2024.109573

Kudriavtsev A, Pastor B, Mirandola A, Pisareva E, Gricourt Y, Capdevila X, Thierry A, Cuvillon P Association of the immediate perioperative dynamics of circulating DNA levels and neutrophil extracellular traps formation in cancer patients. Precis Clin Med. 2024;7(2):pbae008. doi:10.1093/pcmedi/pbae008

What is the role of the neutrophil extracellular traps in the cardiovascular disease burden associated with hemodialysis bioincompatibility?. Frontiers. 2023;10. doi:10.3389/fmed.2023.1268748

Yeh C, Zhou M, Sigel K, Jameson G, White R, Safyan R, Saenger Y, Hecht E, Chabot J, Schreibman S, Ychou M, Conroy T, Fojo T, Manji G, Von Hoff D, Bates S Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data. Oncologist. 2023;28(2):139-148. doi:10.1093/oncolo/oyac217

Bordeau K, Michalet M, Keskes A, Valdenaire S, Debuire P, Cantaloube M, Cabaillé M, Jacot W, Draghici R, Demontoy S, Quantin X, Ychou M, Assenat E, Mazard T, Gauthier L, Dupuy M, Guiu B, Bourgier C, Fenoglietto P, Azria D, Riou O Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study. J Clin Med. 2023;12(3):1183. doi:10.3390/jcm12031183

Aptecar L, Puech C, Lopez-Crapez E, Peter M, Coopman P, D'Hondt V, Freiss G PTPN13 Participates in the Regulation of Epithelial-Mesenchymal Transition and Platinum Sensitivity in High-Grade Serous Ovarian Carcinoma Cells. Int J Mol Sci. 2023;24(20):15413. doi:10.3390/ijms242015413

Pisareva E, Mihalovi?ová L, Mirandola A, Pastor B, Kudriavtsev A, Berger M, Roubille C, Fesler P, Klouche K, Cristol J-P, Thierry A Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J Med Virol. 2023;95(1):e28209. doi:10.1002/jmv.28209

Thierry A Netosis creates a link between diabetes and Long COVID. Physiol Rev. 2023-10-19. doi:10.1152/physrev.00032.2023

Al Amir Dache Z, Thierry A Mitochondria-derived cell-to-cell communication. Cell Rep. 2023;42(7):112728. doi:10.1016/j.celrep.2023.112728

Villemin J-P, Bassaganyas L, Pourquier D, Boissière F, Cabello-Aguilar S, Crapez E, Tanos R, Cornillot E, Turtoi A, Colinge J Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR. Nucleic Acids Res. 2023-05-05. doi:10.1093/nar/gkad352

Faron M, Cheugoua-Zanetsie M, Tierney J, Thirion P, Nankivell M, Winter K, Yang H, Shapiro J, Vernerey D, Smithers B, Walsh T, Piessen G, Nilsson M, Boonstra J, Ychou M, Law S, Cunningham D, de Vathaire F, Stahl M, Urba S, Valmasoni M, Williaume D, Thomas J, Lordick F, Tepper J, Roth J, Gebski V, Burmeister B, Paoletti X, van Sandick J, Fu J, Pignon J-P, Ducreux M, Michiels S Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. J Clin Oncol. 2023;41(28):4535-4547. doi:10.1200/JCO.22.02279

Cherradi S, Garambois V, Marines J, Andrade A, Fauvre A, Morand O, Fargal M, Mancouri F, Ayrolles-Torro A, Vezzo-Vié N, Jarlier M, Loussaint G, Huvelle S, Joubert N, Mazard T, Gongora C, Pourquier P, Boissière-Michot F, Rio M Improving the response to oxaliplatin by targeting chemotherapy-induced CLDN1 in resistant metastatic colorectal cancer cells. Cell Biosci. 2023;13(1):72. doi:10.1186/s13578-023-01015-5

Rouanet P, Castan F, Mazard T, Lemanski C, Nougaret S, Deshayes E, Chalbos P, Gourgou S, Taoum C GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol. Colorectal Dis. 2023;25(10):2078-2086. doi:10.1111/codi.16740

Alouani E, Mercier M, Flecchia C, Auclin E, Hollebecque A, Mazard T, Turpin A, Pernot S, Cohen R, Dutherage M, Kim S, Sclafani F, Ben-Abdelghani M, Herve C, Aparicio T, De La Fouchardière C, Perkins G, Hautefeuille V, Jaffrelot M, Gallois C, Bongard V, Tougeron D, Guimbaud R Efficacy of immunotherapy in mismatch repair-deficient advanced colorectal cancer in routine clinical practice. An AGEO study. ESMO Open. 2023;8(3):101574. doi:10.1016/j.esmoop.2023.101574



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés